These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7878126)

  • 1. Perseveration without hyperlocomotion in a spontaneous alternation task in rats sensitized to the dopamine agonist quinpirole.
    Einat H; Szechtman H
    Physiol Behav; 1995 Jan; 57(1):55-9. PubMed ID: 7878126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and temporal organization of compulsive checking induced by repeated injections of the dopamine agonist quinpirole in an animal model of obsessive-compulsive disorder.
    Dvorkin A; Perreault ML; Szechtman H
    Behav Brain Res; 2006 May; 169(2):303-11. PubMed ID: 16524632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in gut microbiota during development of compulsive checking and locomotor sensitization induced by chronic treatment with the dopamine agonist quinpirole.
    Jung TD; Jung PS; Raveendran L; Farbod Y; Dvorkin-Gheva A; Sakic B; Surette MG; Szechtman H
    Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):211-224. PubMed ID: 29194070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kappa-opioid receptor stimulation quickens pathogenesis of compulsive checking in the quinpirole sensitization model of obsessive-compulsive disorder (OCD).
    Perreault ML; Seeman P; Szechtman H
    Behav Neurosci; 2007 Oct; 121(5):976-91. PubMed ID: 17907829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longlasting consequences of chronic treatment with the dopamine agonist quinpirole for the undrugged behavior of rats.
    Einat H; Szechtman H
    Behav Brain Res; 1993 Mar; 54(1):35-41. PubMed ID: 8099289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D2-agonist quinpirole induces perseveration of routes and hyperactivity but no perseveration of movements.
    Eilam D; Golani I; Szechtman H
    Brain Res; 1989 Jun; 490(2):255-67. PubMed ID: 2527582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism.
    Szechtman H; Talangbayan H; Canaran G; Dai H; Eilam D
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):95-104. PubMed ID: 7862919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats.
    Culver KE; Rosenfeld JM; Szechtman H
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):202-10. PubMed ID: 10972466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats.
    Neisewander JL; Lucki I; McGonigle P
    Pharmacol Biochem Behav; 1996 Apr; 53(4):935-42. PubMed ID: 8801600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase inhibitor-induced blockade of locomotor sensitization to quinpirole: role of striatal dopamine uptake inhibition.
    Culver KE; Rosenfeld JM; Szechtman H
    Neuropharmacology; 2002 Sep; 43(3):385-93. PubMed ID: 12243768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors.
    Culver KE; Szechtman H
    Psychopharmacology (Berl); 2003 May; 167(2):211-8. PubMed ID: 12652347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole.
    Szechtman H; Dai H; Mustafa S; Einat H; Sullivan RM
    Pharmacol Biochem Behav; 1994 Aug; 48(4):921-8. PubMed ID: 7972297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypophysectomy does not block sensitization to the dopamine agonist quinpirole or its modulation by the MAOI clorgyline.
    Culver KE; Szechtman H
    Horm Behav; 2004 Jan; 45(1):23-30. PubMed ID: 14733888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age differences in an animal model of obsessive-compulsive disorder: participation of dopamine: dopamine in an animal model of OCD.
    Ulloa RE; Nicolini H; Fernández-Guasti A
    Pharmacol Biochem Behav; 2004 Aug; 78(4):661-6. PubMed ID: 15301919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No effect of riluzole and memantine on learning deficit following quinpirole sensitization - An animal model of obsessive-compulsive disorder.
    Janikova M; Brozka H; Radostova D; Svoboda J; Stuchlik A
    Physiol Behav; 2019 May; 204():241-247. PubMed ID: 30826389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioural sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia.
    Papp M; Willner P; Muscat R
    Psychopharmacology (Berl); 1993; 110(1-2):159-64. PubMed ID: 7870877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity.
    Johnson EF; Szechtman H
    Behav Pharmacol; 2016 Aug; 27(5):439-50. PubMed ID: 26871406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal immune system activation with lipopolysaccharide enhances behavioural sensitization to the dopamine agonist, quinpirole, in adult female but not male rats.
    Tenk CM; Foley KA; Kavaliers M; Ossenkopp KP
    Brain Behav Immun; 2007 Oct; 21(7):935-45. PubMed ID: 17449223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of clorgyline on sensitization to quinpirole in rats tested in small and large environments.
    Dvorkin A; Culver KE; Szechtman H
    Psychopharmacology (Berl); 2006 Jul; 186(4):534-43. PubMed ID: 16758240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal local cerebral glucose utilization is not altered after behavioral sensitization to quinpirole.
    Richards TL; Pazdernik TL; Levant B
    Neurosci Lett; 2007 Dec; 429(2-3):165-8. PubMed ID: 17997222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.